Improved Radiation Therapy of Hypoxic Tumor Regions by Integrated PET, EPR, and MR Imaging - Resubmission 01
通过集成 PET、EPR 和 MR 成像改进缺氧肿瘤区域的放射治疗 - 重新提交 01
基本信息
- 批准号:9897365
- 负责人:
- 金额:$ 62.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-01-01 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:3-Dimensional3D PrintAffectAnimalsBehaviorBiochemicalBiologicalBlood VesselsBreast CarcinomaCervix UteriChemicalsClinicalDataData CorrelationsDefectDependenceDoseEffectivenessElectrodesElectron Spin Resonance SpectroscopyFranceGoldHead and neck structureHumanHypoxiaImageInbred C3H MiceKineticsMagnetic ResonanceMagnetic Resonance ImagingMalignant NeoplasmsMapsMeasurementMeasuresMethodologyMethodsMisonidazoleMultimodal ImagingMusOrganOutcomeOxygenPaperPartial PressurePatientsPerfusionPeripheralPhase II Clinical TrialsPhysiologicalPositron-Emission TomographyPrecision therapeuticsPredictive ValueProtocols documentationPublicationsRadiationRadiation Dose UnitRadiation therapyRandomizedReportingResearch Project GrantsResistanceSourceStandardizationStatistical MethodsStructureTimeTissuesTranslationsTreatment outcomeTumor VolumeValidationWorkbaseclinical practiceclinically relevantcontrast enhancedexperimental studyfibrosarcomahuman imagingimage guidedimage guided radiation therapyimaging approachimaging modalityimaging systemimprovedinterestmouse modelmultimodalitynovelparametric imagingphysiologic modelpre-clinicalpreclinical studypredictive modelingquantitative imagingradiation deliveryradiation effectradiotracersarcomatherapy outcometooltumortumor hypoxiatumor microenvironmentuptake
项目摘要
Hypoxic resistance to radiation therapy has been known for over a century. However, effective image-guided
approaches to target resistant hypoxic tumor regions have been lacking. A recent publication of the results
from a Phase II clinical trial in France indicates that positron emission tomography (PET) using 18F-fluoro-
misonidazole (FMISO) to define region-of-interest (ROI) for hypoxic tumor targeting was shown to fail in
improving tumor control and treatment outcome. The long-term objective of this proposed research project is to
develop novel integrated multi-modality imaging approaches to effectively guide radiation delivery for
significantly improving therapy precision and treatment outcome of resistant hypoxic tumor regions. Our recent
work in animal studies using electron paramagnetic resonance (EPR) images (EPRI) of absolute pO2 has
demonstrated that targeting the hypoxic regions of tumors with extra radiation dose (i.e., boost in dose
painting) increases tumor cure. This involved novel 3D rapidly printed radiation blocks and conformal animal
radiation. We showed improved tumor cure by comparing uniform radiation delivery of the dose to all tumors
sufficient to cure 15% of tumors (determined in separate experiments) and then randomized to receive extra
doses of radiation to either (1) all hypoxic tumor volumes determined by the EPR pO2 image (pO2 < 10 torr) or
(2) equal volume dose boosts to better-oxygenated tumor. The results showed that treatment (1) offered a
significantly better outcome, including sparing critical organs from damage caused by high dose radiation. This
demonstrates that EPR pO2 images have the potential to guide improved radiation therapy of hypoxic tumors.
Unfortunately, EPR images are currently not available for routine uses in clinical practice. We hypothesize that
using EPRI pO2 images as the gold standard, novel quantitative hypoxia parametric imaging methodologies
based on PET-FMISO data can be established, incorporating consideration and correlation of data from other
clinically available hypoxia-related imaging methods such as dynamic contrast enhanced magnetic resonance
imaging (DCE-MRI) and Iodopamidol diamagnetic chemical exchange saturation transfer (Idia-CEST or
ICEST) pH MRI. These clinically available MRI studies will sharpen the hypoxic tumor region definition for
more effective radiation boost delivery in improving treatment outcomes. We will initially pursue the following
specific aims in animal studies: (1) Implementing and validating novel quantitative multi-modality PET/MR/EPR
imaging methodologies; (2) Developing statistical methodologies for deriving modified parametric images by
integrating multi-modality PET and MRI data in order to emulate EPR images; (3) Employing the established
methods developed in Aim (2) for validation in delivering improved precision radiotherapy of hypoxic tumors to
achieve better treatment outcomes using multi-modality parametric imaging.
耐低氧放射治疗早在一个世纪前就已为人所知。然而,有效的图像引导
靶向耐缺氧肿瘤区域的方法一直缺乏。最近发表的研究结果
来自法国的一项II期临床试验表明,使用18F-氟化物的正电子发射断层扫描(PET)
米索硝唑(FMISO)为低氧肿瘤靶向定义感兴趣区(ROI)的方法被证明失败
改善肿瘤控制和治疗结果。这项拟议研究项目的长期目标是
开发新的集成多模式成像方法,以有效地指导
显著提高耐缺氧肿瘤区域的治疗精度和治疗结果。我们最近
在动物研究中使用绝对pO2的电子顺磁共振(EPR)图像(EPRI)的工作
证明了用额外的辐射剂量(即增加剂量)来靶向肿瘤的缺氧区
绘画)增加了肿瘤的治愈率。这涉及到新的3D快速打印辐射块和适形动物
辐射。通过比较所有肿瘤的均匀辐射剂量,我们显示了肿瘤治愈的改善。
足以治愈15%的肿瘤(在单独的实验中确定),然后随机接受额外的
辐射剂量:(1)由EPR pO2图像确定的所有缺氧性肿瘤体积(pO2和lt;10torr)或
(2)等体积剂量有利于提高肿瘤的氧合能力。结果表明,处理(1)提供了一种
明显更好的结果,包括使关键器官免受高剂量辐射的损害。这
证明EPR pO2图像有可能指导低氧肿瘤的改进放射治疗。
不幸的是,EPR图像目前还不能用于临床实践中的常规使用。我们假设
以EPRI pO2图像为金标准的定量缺氧参数成像新方法
可以建立基于PET-FMISO的数据,纳入对其他数据的考虑和关联
临床可用的低氧相关成像方法,如动态增强磁共振
磁共振成像(DCE-MRI)和碘多巴胺抗磁化学交换饱和转移(IDIA-CEST或
ICEST)pH磁共振。这些临床可用的MRI研究将使缺氧肿瘤区域的定义更加清晰
在改善治疗结果方面,更有效的放射促进传递。我们将初步实现以下目标
动物研究的具体目标:(1)实施和验证新的定量多模式PET/MR/EPR
成像方法;(2)开发统计方法,通过以下方式得出修改后的参数图像
集成多模式PET和MRI数据以模拟EPR图像;(3)使用已建立的
在AIM(2)中开发的方法,用于验证将改进的低氧肿瘤的精确放射治疗传递到
使用多模式参数成像获得更好的治疗结果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Chin-Tu Chen其他文献
Chin-Tu Chen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Chin-Tu Chen', 18)}}的其他基金
Improved Radiation Therapy of Hypoxic Tumor Regions by Integrated PET, EPR, and MR Imaging - Resubmission 01
通过集成 PET、EPR 和 MR 成像改进缺氧肿瘤区域的放射治疗 - 重新提交 01
- 批准号:
10544779 - 财政年份:2020
- 资助金额:
$ 62.33万 - 项目类别:
Improved Radiation Therapy of Hypoxic Tumor Regions by Integrated PET, EPR, and MR Imaging - Resubmission 01
通过集成 PET、EPR 和 MR 成像改进缺氧肿瘤区域的放射治疗 - 重新提交 01
- 批准号:
10314063 - 财政年份:2020
- 资助金额:
$ 62.33万 - 项目类别:
Improved Radiation Therapy of Hypoxic Tumor Regions by Integrated PET, EPR, and MR Imaging - Resubmission 01 - Revision - 1
通过集成 PET、EPR 和 MR 成像改进缺氧肿瘤区域的放射治疗 - 重新提交 01 - 修订版 - 1
- 批准号:
10289582 - 财政年份:2020
- 资助金额:
$ 62.33万 - 项目类别:
PET imaging of a4b2 nicotinic receptor upregulation and smoking cessation
a4b2 烟碱受体上调和戒烟的 PET 成像
- 批准号:
9919536 - 财政年份:2017
- 资助金额:
$ 62.33万 - 项目类别:
PET imaging of a4b2 nicotinic receptor upregulation and smoking cessation
a4b2 烟碱受体上调和戒烟的 PET 成像
- 批准号:
9403663 - 财政年份:2017
- 资助金额:
$ 62.33万 - 项目类别:
PET imaging of a4b2 nicotinic receptor upregulation and smoking cessation
a4b2 烟碱受体上调和戒烟的 PET 成像
- 批准号:
10152562 - 财政年份:2017
- 资助金额:
$ 62.33万 - 项目类别:
An MR-Compatible Small Animal SPECT Based on Artifical Compound Eye Cameras
基于人工复眼相机的 MR 兼容小动物 SPECT
- 批准号:
9252072 - 财政年份:2016
- 资助金额:
$ 62.33万 - 项目类别:
An MR-Compatible Small Animal SPECT Based on Artifical Compound Eye Cameras
基于人工复眼相机的 MR 兼容小动物 SPECT
- 批准号:
9752622 - 财政年份:2016
- 资助金额:
$ 62.33万 - 项目类别:
An MR-Compatible Small Animal SPECT Based on Artifical Compound Eye Cameras
基于人工复眼相机的 MR 兼容小动物 SPECT
- 批准号:
9353404 - 财政年份:2016
- 资助金额:
$ 62.33万 - 项目类别:
An Ultra High Resolution SPECT System Integrated with a High-Field MRI Scanner
与高场 MRI 扫描仪集成的超高分辨率 SPECT 系统
- 批准号:
8496038 - 财政年份:2011
- 资助金额:
$ 62.33万 - 项目类别:
相似海外基金
Study on the use of 3D print models to improve understanding of geomorphic processes
研究使用 3D 打印模型来提高对地貌过程的理解
- 批准号:
22K13777 - 财政年份:2022
- 资助金额:
$ 62.33万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
3D print-on-demand technology for personalised medicines at the point of care
用于护理点个性化药物的 3D 按需打印技术
- 批准号:
10045111 - 财政年份:2022
- 资助金额:
$ 62.33万 - 项目类别:
Grant for R&D
Regenerative cooling optimisation in 3D-print rocket nozzles
3D 打印火箭喷嘴的再生冷却优化
- 批准号:
2749141 - 财政年份:2022
- 资助金额:
$ 62.33万 - 项目类别:
Studentship
Development of a New Powder Mix and Process Plan to 3D Print Ductile Iron Parts
开发用于 3D 打印球墨铸铁零件的新粉末混合物和工艺计划
- 批准号:
548945-2019 - 财政年份:2021
- 资助金额:
$ 62.33万 - 项目类别:
College - University Idea to Innovation Grants
Development of a New Powder Mix and Process Plan to 3D Print Ductile Iron Parts
开发用于 3D 打印球墨铸铁零件的新粉末混合物和工艺计划
- 批准号:
548945-2019 - 财政年份:2020
- 资助金额:
$ 62.33万 - 项目类别:
College - University Idea to Innovation Grants
Administrative Supplement for Equipment: 6-axis Positioner to Improve 3D Print Quality and Print Size
设备管理补充:用于提高 3D 打印质量和打印尺寸的 6 轴定位器
- 批准号:
10801667 - 财政年份:2019
- 资助金额:
$ 62.33万 - 项目类别:
SBIR Phase II: Pellet based 3D print extrusion process for shoe manufacturing
SBIR 第二阶段:用于制鞋的基于颗粒的 3D 打印挤出工艺
- 批准号:
1738138 - 财政年份:2017
- 资助金额:
$ 62.33万 - 项目类别:
Standard Grant
Development of "artificial muscle' ink for 3D print of microrobots
开发用于微型机器人3D打印的“人造肌肉”墨水
- 批准号:
17K18852 - 财政年份:2017
- 资助金额:
$ 62.33万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
I-Corps: Nanochon, a Commercial Venture to 3D Print Regenerative Implants for Joint Reconstruction
I-Corps:Nanochon,一家商业企业,致力于 3D 打印再生植入物进行关节重建
- 批准号:
1612567 - 财政年份:2016
- 资助金额:
$ 62.33万 - 项目类别:
Standard Grant
SBIR Phase I: Pellet based 3D print extrusion process for shoe manufacturing
SBIR 第一阶段:用于制鞋的基于颗粒的 3D 打印挤出工艺
- 批准号:
1621732 - 财政年份:2016
- 资助金额:
$ 62.33万 - 项目类别:
Standard Grant